Shire Boosts R&D In Rare Diseases | Chemical & Engineering News
Volume 90 Issue 48 | p. 19 | Concentrates
Issue Date: November 26, 2012

Shire Boosts R&D In Rare Diseases

Department: Business
Keywords: rare disease, pediatrics

The British drug company Shire is increasing its rare disease research efforts. With Boston Children’s Hospital, Shire has formed a three-year rare pediatric disease collaboration. After making a payment to the hospital, Shire will have the right to fund selected research programs and an option to license them. Separately, Shire has entered a research pact with the Italian charity Fondazione Telethon on 13 undisclosed rare diseases. Shire will provide $22 million in funding to the charity over five years. And Shire is launching a report to gauge the health, psychosocial, societal, and economic impact of rare diseases.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment